Long-term hematopoietic reconstitution in adults undergoing BMT
. | . | LTC-ICs, per 106 MNC . | . | |
|---|---|---|---|---|
| Patient no. . | Disease . | 1 y after BMT . | 5 y after BMT . | |
| 1 | CML | 0 | 2.6 | |
| 2 | CML | 2 | 0 | |
| 3 | CML | 0 | 2 | |
| 4 | CML | 0 | — | |
| 5 | AL | 0 | 0 | |
| 6 | AL | 2 | 2 | |
| 7 | AL | 0 | 0 | |
| 8 | AL | 2.2 | 1 | |
| 9 | AL | 0 | 0 | |
| 10 | AA | 1.5 | 2 | |
| 11 | AA | 0 | 0 | |
| 12 | AA | 0 | 2.1 | |
| 13 | AA | 1 | 2 | |
| Median | 0 | 0.8 | ||
| Range | 0-2.2 | 0-2.6 | ||
. | . | LTC-ICs, per 106 MNC . | . | |
|---|---|---|---|---|
| Patient no. . | Disease . | 1 y after BMT . | 5 y after BMT . | |
| 1 | CML | 0 | 2.6 | |
| 2 | CML | 2 | 0 | |
| 3 | CML | 0 | 2 | |
| 4 | CML | 0 | — | |
| 5 | AL | 0 | 0 | |
| 6 | AL | 2 | 2 | |
| 7 | AL | 0 | 0 | |
| 8 | AL | 2.2 | 1 | |
| 9 | AL | 0 | 0 | |
| 10 | AA | 1.5 | 2 | |
| 11 | AA | 0 | 0 | |
| 12 | AA | 0 | 2.1 | |
| 13 | AA | 1 | 2 | |
| Median | 0 | 0.8 | ||
| Range | 0-2.2 | 0-2.6 | ||
CML indicates chronic myelogenous leukemia; AL, acute leukemia; AA, aplastic anemia; and —, not done